Successful Use of Certolizumab Pegol for Refractory Psoriatic Arthritis Triggered by COVID-19 Infection. Ohmura SI, Homma Y, Hanai S, Miyamoto T, et al. Intern Med 2022;61:433-438.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ohmura SI, Homma Y, Hanai S, Miyamoto T, et al. Successful Use of Certolizumab Pegol for Refractory Psoriatic Arthritis Triggered by COVID-19 Infection. Intern Med 2022;61:433-438.
PMID: 34803106